Lipid Nanoparticles Immunogenicity and Toxicity
Evvnt Promotion / evvnt
Archive
06.12.2022 - 08.12.2022 Hyatt Regency Boston, 1 Avenue de Lafayette, Massachusetts, 02111 Boston, USA
Time: 09:00 to 16:00
Conference themes
Enhance Your Prediction of PKPD, Accurate Dosing Regime and Immuno-Modulation of LNP for Long-Term Patient Safety and Potency
Following the success of LNP-mRNA vaccines, we have seen an influx of novel types of lipids based nanocarriers over the last 12 months, progress has been made to minimize immuno-toxicity challenges – from maximizing therapeutic window to fine-tuning the immune response.
Enhance Your Prediction of PKPD, Accurate Dosing Regime and Immuno-Modulation of LNP for Long-Term Patient Safety and Potency
Following the success of LNP-mRNA vaccines, we have seen an influx of novel types of lipids based nanocarriers over the last 12 months, progress has been made to minimize immuno-toxicity challenges – from maximizing therapeutic window to fine-tuning the immune response.
Professional congress organizer (PCO)
Molly Sullivan
Molly Sullivan
Notes
Brochure: https://go.evvnt.com/1289158-3?pid=4832
Speakers: Vibha Jawa, Executive Director, Bristol Myers Squibb, Tao Niu, Associate Director, Modeling and Simulations, Vertex Pharmaceuticals, and more
Brochure: https://go.evvnt.com/1289158-3?pid=4832
Speakers: Vibha Jawa, Executive Director, Bristol Myers Squibb, Tao Niu, Associate Director, Modeling and Simulations, Vertex Pharmaceuticals, and more
Enquiries and Registration:
https://go.evvnt.com/1289158-2?pid=4832
Ms. Molly Sullivan
General Medicine
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
